Vineet Laboratories Limited share price

NSE: VINEETLAB · ISIN INE505Y01010

Key numbers

Market cap
₹ 66.9 Cr
Current price
₹ 34.85
52-week high / low
₹ 50 / 28
Stock P/E
34.9
Book value
₹ 15.3
Dividend yield
0.00%
ROCE
8.5%
ROE
3.7%
Debt to equity
0.99
Sales growth (3 yrs)
-34.6%
Profit growth (3 yrs)
-3.9%
1-year return
-3.5%

About Vineet Laboratories Limited

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

Quarterly results

Consolidated figures in ₹ crores

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales147171619
Operating profit-110323
Net profit-11-1011
EPS (₹)-10.41-0.790.360.920.43

Peers in Chemicals

Data for information only, not investment advice. Prices end of day.